Chemorbit Lifesciences Private Limited - Due diligence report

A 360° intelligence report on Chemorbit Lifesciences Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2019-04-09 Bahadurgarh, Haryana Active Unlisted
Connect MCP
CL Chemorbit Lifesciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Chemorbit Lifesciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
89/100
Trust Score
Low Risk

Chemorbit Lifesciences Private Limited is assessed as Low Risk with a Trust Score of 89/100. Chemorbit Lifesciences Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Chemorbit Lifesciences Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
89/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BHAGYASRI BONDILI 01234567 Director 01/04/2018 6 yrs Approved
POOJA NIRAJKUMAR LAKHOTIYA 01234567 Director 01/04/2018 6 yrs Approved
RAKESH KUMAR 01234567 Director 01/04/2018 6 yrs Approved
RAVINDER SINGH 01234567 Director 01/04/2018 6 yrs Approved
NIRAJ GOKULDAS LAKHOTIYA 01234567 Director 01/04/2018 6 yrs Approved
MANOHAR LAL 01234567 Director 01/04/2018 6 yrs Approved
ARUN GODARA 01234567 Director 01/04/2018 6 yrs Approved
BONDILI RAJESH 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 80
Growth signals & trust indicators
Operating for 7 years.
Distress signals & risk flags
Profit declined two years in a row.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence91/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment91/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Mar 2020
Securities allotted
10000 Equity Shares Without Differential Rights - 1.00 Lakh raised
02 Oct 2019
Director appointed
MANOHAR LAL (Director)
01 Sep 2019
Director appointed
BHAGYASRI BONDILI (Director)
Director appointed
POOJA NIRAJKUMAR LAKHOTIYA (Director)
Director appointed
RAKESH KUMAR (Director)
Director appointed
RAVINDER SINGH (Director)
09 Apr 2019
Incorporated
Registered with Roc Haryana
Director appointed
NIRAJ GOKULDAS LAKHOTIYA (Director)
Director appointed
ARUN GODARA (Director)
Director appointed
BONDILI RAJESH (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vasundhra Arts And Prints Private Limited U22219WB2006PTC109218 Kolkata, West Bengal, India
Raunak Exports Pvt Ltd U15314WB1996PTC079298 Kol, West Bengal, India
Rasmita Ply And Hardware Traders Private Limited U51909OR2020PTC034956 Bhubaneswar, Orissa, India
Pone Engineering India Private Limited U29253TN2014PTC098295 Chennai, Tamil Nadu, India
Aeon Procare U26990MH2016PTC283627 Mumbai, Maharashtra, India
Oxygen Remedies Private Limited U85191UP2010PTC041507 Kanpur, Uttar Pradesh, India
Qunying Machinery Private Limited U29309GJ2019PTC108549 Dascroi, Gujarat, India
Jamna Dass And Sons Traders Private Limited U51909DL2010PTC200554 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Chemorbit Lifesciences Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Chemorbit Lifesciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 50/100, margin trends, ownership structure and peer set for Chemorbit Lifesciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 89/100, distress signals and MSME payment-delay disclosures - know whether Chemorbit Lifesciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Chemorbit Lifesciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Chemorbit Lifesciences Private Limited an active company?

Chemorbit Lifesciences Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Chemorbit Lifesciences Private Limited financially healthy?

Chemorbit Lifesciences Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Chemorbit Lifesciences Private Limited?

Its overall Trust Score is 89/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Chemorbit Lifesciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Chemorbit Lifesciences Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Chemorbit Lifesciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Chemorbit Lifesciences Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.